Literature DB >> 2992561

The effect of captopril on the reflex control heart rate: possible mechanisms.

A A Ajayi, B C Campbell, P A Meredith, A W Kelman, J L Reid.   

Abstract

Angiotensin converting enzyme inhibitors reduce blood pressure without reflex tachycardia, possibly as a result of enhanced hypothesis that this results from the removal of the parasympathetic activity. We examined the vagolytic action of angiotensin II or alternatively by acetylcholinesterase inhibition. Both captopril and [Sar1ala8] angiotensin II, (saralasin), caused modest falls in blood pressure, without increasing heart rate in normotensive subjects. Captopril and saralasin significantly attenuated the vagally mediated heart rate slowing after facial immersion in water. There was a close correlation between the effects produced by captopril and saralasin on the diving reflex. Infusion of subpressor doses of angiotensin II, reversed the hypotensive effect of captopril and returned the bradycardia after facial immersion to placebo level. In vitro neither captopril nor enalapril or lisinopril affected bovine erythrocyte acetylcholinesterase activity. The parasympathetic effect of angiotensin converting enzyme inhibitors appear to reflect a direct consequence of the removal of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992561      PMCID: PMC1400633          DOI: 10.1111/j.1365-2125.1985.tb02793.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Central pressor effect of angiotensin mediated by the parasympathetic nervous system.

Authors:  G C Scroop; R D Lowe
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

2.  Acetylcholinesterase hydrolyzes substance P.

Authors:  I W Chubb; A J Hodgson; G H White
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

Review 3.  Adrenergic facilitation by angiotensin: does it serve a physiological function?

Authors:  B G Zimmerman
Journal:  Clin Sci (Lond)       Date:  1981-04       Impact factor: 6.124

4.  Angiotensin inhibits action of vagus nerve at the heart.

Authors:  E K Potter
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

5.  Mechanisms by which angiotensin II affects the heart rate of the conscious sheep.

Authors:  W B Lee; M J Ismay; E R Lumbers
Journal:  Circ Res       Date:  1980-08       Impact factor: 17.367

6.  Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man.

Authors:  A A Ajayi; B C Campbell; C A Howie; J L Reid
Journal:  J Hypertens       Date:  1985-02       Impact factor: 4.844

7.  Autonomic pathways responsible for bradycardia on facial immersion.

Authors:  J P Finley; J F Bonet; M B Waxman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-12

8.  Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.

Authors:  A N Shepherd; B C Campbell; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1982 May-Jun       Impact factor: 3.105

9.  Autonomic control of the immediate heart rate response to lying down.

Authors:  F Bellavere; D J Ewing
Journal:  Clin Sci (Lond)       Date:  1982-01       Impact factor: 6.124

10.  Long-term converting enzyme inhibition and sympathetic nerve function in hypertensive humans.

Authors:  M T Zanella; E L Bravo; F M Fouad; R C Tarazi
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

View more
  15 in total

1.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  The influence of cilazapril on indices of autonomic function in normotensives and hypertensives.

Authors:  H L Elliott; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 3.  Cardiac effects of angiotensin converting enzyme inhibitors.

Authors:  N Sharpe
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

4.  The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

Authors:  A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

5.  Enalapril and baroreflex function in normotensive subjects.

Authors:  J F Giudicelli; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

6.  Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.

Authors:  A A Ajayi; N Hockings; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 7.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

8.  Antihypertensive effect of single doses of enalapril in hypertensive patients treated with bendrofluazide.

Authors:  J Webster; D Newnham; O J Robb; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 9.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

10.  Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.

Authors:  D H Roberts; Y Tsao; S F Grimmer; P A Winstanley; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.